{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "ULBI",
  "name": "Ultralife Corporation",
  "url": "https://frontierpicks.com/dossiers/ULBI/",
  "json_url": "https://frontierpicks.com/dossiers/ULBI.json",
  "status": "WATCHLIST",
  "current_conviction": "LOW",
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "Ultralife trades as a capped claim on EnerSys's $16.00-per-share cash offer, so it is more likely to lag the S&P 500 than lead it; US and UK clearances and the tender, first due to expire on 3 December 2026, settle whether holders are paid.",
  "invalidation_trigger": "A daily close below $15.00, under the $15.61 reported on 2026-10-28 after the deal was announced, which would show the market doubting EnerSys's $16.00 cash offer. Termination of the merger agreement or a US or UK regulatory block would also end the case.",
  "catalyst_date": "2026-11-11",
  "portfolio": null,
  "pick": null,
  "themes": [
    "m-and-a-special-situations"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Ultralife is subject to a two-step acquisition: EnerSys's cash tender offer, followed by a merger under Delaware Section 251(h) without a stockholder vote if the tender succeeds.",
    "Chair Bradford Whitmore and affiliated entities own about 40.3% of the shares and signed a support agreement; that stake alone does not meet the more-than-50% minimum tender condition.",
    "The offer needs both US Hart-Scott-Rodino antitrust clearance and UK National Security and Investment Act clearance, and EnerSys is not required to accept divestitures."
  ],
  "source_links": [
    {
      "title": "ULTRALIFE CORP - Form SC 14D9 - FY2026",
      "url": "https://www.sec.gov/Archives/edgar/data/0000875657/000143774926033810/ulbi20261028_sc14d9.htm",
      "date": null
    },
    {
      "title": "ULTRALIFE CORP - Form SC TO-T - FY2026",
      "url": "https://www.sec.gov/Archives/edgar/data/0000875657/000119312526435071/d153599dex99a1a.htm",
      "date": null
    },
    {
      "title": "ULTRALIFE CORP - Form 10-Q - FY2026",
      "url": "https://www.sec.gov/Archives/edgar/data/0000875657/000143774926035323/ulbi20260930_10q.htm",
      "date": null
    },
    {
      "title": "EnerSys To Acquire Ultralife, Expanding Differentiated Battery Technologies and Accelerating Growth in Defense Market",
      "url": "https://investor.enersys.com/news/news-details/2026/EnerSys-To-Acquire-Ultralife-Expanding-Differentiated-Battery-Technologies-and-Accelerating-Growth-in-Defense-Market/default.aspx",
      "date": null
    },
    {
      "title": "ULTRALIFE CORP - Form 8-K - FY2026",
      "url": "https://www.sec.gov/Archives/edgar/data/0000875657/000143774926033731/ulbi20261027_8k.htm",
      "date": "2026-10-27"
    },
    {
      "title": "business-news-today.com",
      "url": "https://business-news-today.com/enersys-targets-20m-in-savings-from-320m-ultralife-deal-as-tender-deadline-approaches/",
      "date": "2026-11-01"
    },
    {
      "title": "greenstocknews.com",
      "url": "https://www.greenstocknews.com/news/nyse/ens/enersys-announces-date-of-second-quarter-fiscal-2027-financial-results-release-and-conference-call",
      "date": null
    },
    {
      "title": "At a 166% premium, EnerSys (ENS) agrees to buy Ultralife for cash.",
      "url": "https://www.stocktitan.net/sec-filings/ENS/8-k-ener-sys-reports-material-event-08a929489dfb.html",
      "date": null
    }
  ],
  "evidence": [
    {
      "claim": "EnerSys agreed to acquire Ultralife for $16.00 per share in cash, about $320 million including net debt and a 166% premium to the $6.01 close on 2026-10-26.",
      "source": "EnerSys press release and Ultralife Form 8-K, 2026-10-27",
      "as_of": "2026-10-27"
    },
    {
      "claim": "The tender offer and withdrawal rights expire at 5:00 p.m. New York City time on 2026-12-03 unless extended.",
      "source": "Schedule TO-T offer documents filed 2026-10-28",
      "as_of": "2026-10-28"
    },
    {
      "claim": "For the cash tender offer, the HSR waiting period runs 15 calendar days after filing unless ended early or extended by a second request; the parties agreed to file within 10 business days of signing.",
      "source": "Schedule TO-T offer to purchase",
      "as_of": "2026-10-28"
    },
    {
      "claim": "Bradford Whitmore and affiliated entities beneficially own 6,708,835 shares, about 40.3% of those outstanding, and agreed to tender under a support agreement.",
      "source": "Ultralife Schedule 14D-9",
      "as_of": "2026-10-28"
    },
    {
      "claim": "The company and reverse termination fees are each $10.3 million; the reverse fee is payable in specified antitrust-related circumstances.",
      "source": "Ultralife Schedule 14D-9",
      "as_of": "2026-10-28"
    },
    {
      "claim": "Third-quarter revenue was $48.271 million against $43.371 million a year earlier; EPS was $0.14 against a $0.07 loss.",
      "source": "Ultralife Q3 2026 results release 2026-11-05 and 10-Q",
      "as_of": "2026-09-30"
    },
    {
      "claim": "Ultralife had $45.125 million of term loan principal, $5.875 million drawn on its revolver and $8.628 million of cash, including $1.0 million restricted.",
      "source": "Ultralife 10-Q for the quarter ended 2026-09-30",
      "as_of": "2026-09-30"
    },
    {
      "claim": "EnerSys expects the transaction to close in the first quarter of 2027, subject to HSR Act and UK NSIA clearance and a majority tender.",
      "source": "EnerSys investor relations release",
      "as_of": "2026-10-27"
    }
  ],
  "view_changes": [],
  "body_markdown": "## Current Thesis\n\nUltralife trades as a capped claim on EnerSys's $16.00-per-share cash offer, so the shares are more likely to lag the S&P 500 than lead it over the next three months. US antitrust clearance, UK national security clearance and the tender offer, first due to expire on 2026-12-03, decide whether holders are paid.\n\nEnerSys agreed on 2026-10-27 to buy Ultralife for about $320 million including net debt, a 166% premium to the $6.01 close on 2026-10-26, according to the merger press release. The shares closed at $15.79 on 2026-11-10, a 52-week high that still sits under the $16.00 cash price. A competing proposal above $16.00 would show the upside is not capped.\n\nSearches of company news and filings on 2026-11-11 found no competing bid, no notice that the US waiting period has ended and no amendment moving the expiry date. The narrative is saturated: the price has been public since 2026-10-27, and the shares have moved only from $15.61 on 2026-10-28 to $15.79 on 2026-11-10 as the time to closing shortens.\n\n## Bull Case\n\n- **Cash offer with no financing condition.** EnerSys will pay from existing cash, which stood at about $530.7 million on 2026-07-05, Business News Today reported on 2026-11-01. The merger agreement has no financing condition.\n- **Largest holder is committed.** Chair Bradford Whitmore and affiliated entities, with 6,708,835 shares or about 40.3%, signed a support agreement to tender, the Schedule 14D-9 filed 2026-10-28 shows. The offer needs more than 50% of outstanding shares.\n- **Board and insiders back the price.** The board unanimously recommended the offer, and each executive officer and director intends to tender, per the Schedule 14D-9. StoneX gave its fairness opinion on 2026-10-27.\n- **The price was negotiated upward.** EnerSys opened at $12.00 to $14.00 per share on 2026-07-06 and reached $16.00 on 2026-10-09 after Ultralife countered at $18.00 and $17.00, per the Schedule 14D-9.\n- **The business improved into the deal.** Ultralife reported on 2026-11-05 that third-quarter revenue rose to $48.271 million from $43.371 million a year earlier. Earnings per share were $0.14 against a $0.07 loss, per the results release and the 10-Q for the quarter ended 2026-09-30.\n\n## Bear Case\n\n- **Upside is small, downside is large.** The $16.00 cash price sits just above the $15.79 close on 2026-11-10, while the last price before the deal was $6.01 on 2026-10-26. A failed deal would reopen most of that gap.\n- **Two regulators must clear it.** The offer is conditioned on the US Hart-Scott-Rodino (HSR) antitrust waiting period and UK National Security and Investment Act clearance, and EnerSys is not required to accept divestitures, per the Schedule 14D-9. No public filing located by 2026-11-11 confirms either clearance.\n- **Break protection is modest.** The reverse termination fee is $10.3 million and is payable only in specified antitrust-related circumstances, per the Schedule 14D-9.\n- **Standalone value rests on a steep plan.** Management's projections in the Schedule 14D-9 lift revenue from $208.3 million in 2026 to $266.2 million in 2029. StoneX's comparable-company range was $9.1 to $13.3 per share.\n- **Debt would remain after a break.** At 2026-09-30 Ultralife had $45.125 million of term loan principal and $5.875 million drawn on its revolver against $8.628 million of cash, including $1.0 million restricted, per the 10-Q.\n- **Price challenge is being probed.** Ademi LLP said on 2026-10-28 it is investigating whether the buyout gives fair value to shareholders. Such inquiries are common in cash takeovers and have not altered the terms.\n\n## Setup & Price Structure\n\nThe shares closed at $15.79 on 2026-11-10, equal to their 52-week high, after closing at $15.69 on 2026-11-09 and $15.61 on 2026-10-28, per adjusted daily closes. They have risen 112.2% over three months, almost all of it in the one-day repricing after the 2026-10-27 announcement.\n\nThe 14-day relative strength index (RSI) reads 97.9. In a pending cash takeover that reading reflects the jump to the offer price and the slow drift toward $16.00 since, rather than momentum buying. The price now moves with perceived deal risk and time to payment.\n\nCrowding is limited to the deal itself. No insider sales or share issuance appear in SEC filings since signing, and the directors and officers have said they will tender. The next scheduled update from either party is EnerSys's results on 2026-11-11.\n\n## Catalyst Calendar (next 30 days)\n\n- **2026-11-11, after the close:** EnerSys fiscal second-quarter results, with a call at 9:00 a.m. ET on 2026-11-12. It is the acquirer's first scheduled public update since signing and may address regulatory filings and closing timing.\n- **~2026-11-25 (est.):** End of the HSR waiting period, if the filing was made by the 10-business-day deadline. The offer documents set a 15-calendar-day waiting period for a cash tender offer unless ended early or extended by a second request.\n- **2026-12-03, 5:00 p.m. New York City time:** Initial expiry of the tender offer. An extension fits the first-quarter 2027 closing guidance; a termination or a regulatory objection would break the case.\n- **2027-04-27:** Outside date under the merger agreement, subject to extensions, after which the deal can lapse if conditions remain unmet.\n\n## What Would Change Our Mind\n\nThe case breaks if the merger agreement is terminated, if US antitrust agencies issue a second request that EnerSys will not resolve, or if the UK government calls in the deal under its national security law. A tender count below 50% once regulatory conditions are met would also end it.\n\nThe case would turn more positive on a competing proposal above $16.00. It would also strengthen if both clearances arrived early and the expiry stayed at 2026-12-03, since faster payment raises the return from the remaining gap.\n\nOn price, a daily close below $15.00 would show the market doubting the $16.00 cash offer. That level sits under the $15.61 reported on 2026-10-28, the first full session after the announcement.\n\n## Correlation Notes\n\nWhile the deal stands, the shares track the probability and timing of the $16.00 payment rather than the S&P 500 or defense-equipment peers such as CDRE, KRMN and SARO. Gains in those peers do not lift Ultralife above the cash price.\n\nThe link to EnerSys (ENS) runs through deal risk: news on EnerSys's balance sheet, regulatory progress or strategy at its 2026-11-11 results moves Ultralife's gap to $16.00. If the deal failed, Ultralife would revert to trading as a small battery and communications-systems supplier to defense customers, with prices last set at $6.01 on 2026-10-26.",
  "first_seen": "2026-11-06",
  "last_analyzed": "2026-11-11T03:36:37+00:00",
  "last_synthesized": "2026-11-11",
  "date_modified": "2026-11-11",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}